onychomycosis
Conditions
Interventions
3:laser treatment
Sponsors
Department of Dermatology, Beijing Friendship Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: The study was approved by the ethics committee. Patients aged 18-60 years with typical onychomycosis-related symptoms, who were positive by direct microscopy examination, were enrolled in the study. All patients provided written informed consent, and were available for timely follow-up visits. Topical antifungal agents were prohibited for one month, and systemic antifungal agents for six months.
Exclusion criteria
Exclusion criteria: The exclusion criteria included patients who (1) automatically withdrew or changed the treatment regimen or follow-up plan; (2) received other antifungal therapy or agents affecting the outcome during the study; (3) showed continuous or semi-continuous nail discoloration, for example, abnormal nail pigmentation caused by the use of topical antifungal therapy such as Castellani solution, nail coloring dyes or polishes containing magnesium and iron, or occupational exposure to colorants or bitumen, regardless of the therapeutic or cosmetic purpose; (4) used photosensitivity-inducing medications within six months; (5) were pregnant; (6) had subungual hematoma or nevoid formation, and (7) had other concomitant onychopathy-induced diseases such as nail-plate psoriasis, lichen planus, and atopic dermatitis. Those who withdrew from the study due to side effects were analyzed for side effects but not for efficacy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| clinical efficacy; | — |
Countries
China
Contacts
Public ContactJunying Zhao
Beiijng Friendship Hospital
Outcome results
None listed